Medin; Jeffrey A.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Medin; Jeffrey A..The latest application filed is for "t-rapa cells as novel effector cell type for chimeric antigen receptor therapy".
- Medin; Jeffrey A. - Shorewood WI
- MEDIN; Jeffrey A. - North York CA
- Medin; Jeffrey A - North York N/A CA
- Medin; Jeffrey A. - Toronto CA
| Patent | Date |
|---|---|
| T-Rapa Cells as Novel Effector Cell Type for Chimeric Antigen Receptor Therapy App 20220016167 - Medin; Jeffrey A. ; et al. | 2022-01-20 |
| Use of Lentivector-Transduced T-RAPA Cells for Amelioration of Lysosomal Storage Disorders App 20210322472 - Medin; Jeffrey A. ; et al. | 2021-10-21 |
| Novel In Vitro And In Vivo Enrichment Strategy Targeting Lymphocytes Derived From Vector Transduced Hscs For Therapy Of Disorder App 20200181582 - Medin; Jeffrey A. ; et al. | 2020-06-11 |
| Anti-cd30 Antibodies And Methods Of Use App 20200095329 - MEDIN; JEFFREY A. ; et al. | 2020-03-26 |
| System And Method For The Development Of Cd30 Bispecific Antibodies For Immunotherapy Of Cd30+ Malignancies App 20200095330 - Medin; Jeffrey A. ; et al. | 2020-03-26 |
| Il-12 Immunotherapy For Cancer App 20200038457 - MEDIN; Jeffrey A. ; et al. | 2020-02-06 |
| IL-12 immunotherapy for cancer Grant 10,258,653 - Medin , et al. | 2019-04-16 |
| Thymidylate kinase fusions and uses thereof Grant 10,137,205 - Medin , et al. November 27, 2 | 2018-11-27 |
| IL-12 immunotherapy for cancer Grant 10,022,405 - Medin , et al. July 17, 2 | 2018-07-17 |
| Il-12 Immunotherapy For Cancer App 20170136072 - MEDIN; Jeffrey A. ; et al. | 2017-05-18 |
| Thymidylate Kinase Fusions And Uses Thereof App 20170056527 - Medin; Jeffrey A. ; et al. | 2017-03-02 |
| Thymidylate kinase fusions and uses thereof Grant 9,439,980 - Medin , et al. September 13, 2 | 2016-09-13 |
| Compositions And Methods For Cancer Treatment App 20160250309 - Medin; Jeffrey A. ; et al. | 2016-09-01 |
| IL-12 Immunotherapy for Cancer App 20160130317 - MEDIN; JEFFREY A. ; et al. | 2016-05-12 |
| Vector Encoding Therapeutic Polypeptide And Safety Elements To Clear Transduced Cells App 20160074533 - Medin; Jeffrey A. | 2016-03-17 |
| Il-12 Immunotherapy For Cancer App 20140370039 - Medin; Jeffrey A. ; et al. | 2014-12-18 |
| Compositions And Methods For Cancer Treatment App 20140193449 - Medin; Jeffrey A. ; et al. | 2014-07-10 |
| IL-12 immunotherapy for cancer Grant 8,765,462 - Medin , et al. July 1, 2 | 2014-07-01 |
| Thymidylate Kinase Fusions And Uses Thereof App 20140093485 - MEDIN; JEFFREY A. ; et al. | 2014-04-03 |
| Thymidylate kinase fusions and uses thereof Grant 8,568,709 - Medin , et al. October 29, 2 | 2013-10-29 |
| Modified H2 relaxin for tumor suppression Grant 8,445,635 - Medin , et al. May 21, 2 | 2013-05-21 |
| Thymidylate Kinase Fusions And Uses Thereof App 20110104130 - Medin; Jeffrey A. ; et al. | 2011-05-05 |
| Compositions and Methods for Cancer Treatment App 20110027310 - Medin; Jeffrey A. ; et al. | 2011-02-03 |
| Thymidylate Kinase Mutants and Uses Thereof App 20110014165 - Medin; Jeffrey A. ; et al. | 2011-01-20 |
| Il-12 Immunotherapy For Cancer App 20100291043 - Medin; Jeffrey A. ; et al. | 2010-11-18 |
| Modified H2 Relaxin For Tumor Suppression App 20100286046 - Medin; Jeffrey A ; et al. | 2010-11-11 |
| Vector Encoding Therapeutic Polypeptide And Safety Elements To Clear Transduced Cells App 20100233200 - Medin; Jeffrey A. | 2010-09-16 |
| Thymidylate Kinase Mutants And Uses Thereof App 20090074733 - Medin; Jeffrey A. ; et al. | 2009-03-19 |
| Thymidylate Kinase Mutants And Uses Thereof App 20090068158 - Medin; Jeffrey A. ; et al. | 2009-03-12 |
| Generation of use of tc1 and tc2 cells App 20040258661 - Fowler, Daniel ; et al. | 2004-12-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 